Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
US7572459B2 · kind B2 · utility
9Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2002 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Feb 21, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To inhibit, prophylactically or therapeutically, a bacterial, yeast, fungal, or parasitic agent in a patient, an effective amount of a dendrimer is administered to the patient, which dendrimer has a plurality of terminal groups, at least one of which has an anionic- or cationic-moiety covalently bonded or linked thereto. The anionic-containing moiety is not a disaccharide or oligosaccharide moiety, and, where the anionic-containing moiety is a neuraminic- or sialic acid-containing moiety, it is modified in the 4-position by substitution with an amino, amido, cyano, azido or guanido group, or is unsaturated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.